Loening S A
Department of Urology, Charité Medical School, Humboldt University, Berlin, Germany.
Semin Surg Oncol. 1997 Nov-Dec;13(6):419-24. doi: 10.1002/(sici)1098-2388(199711/12)13:6<419::aid-ssu5>3.0.co;2-d.
Interstitial brachytherapy for treatment of prostate cancer with radioactive gold--initially with liquid gold and later with seed technique--is based on an experience of more than four decades. With biopsy results approaching a 80% negative rate, and, at 5 years, a cancer specific survival of 100% for Stages A and B1, 90% for Stage B2, and 76% for Stage C, this form of treatment offers an effective and well-tolerated alternative mode of therapy for patients with localized prostate cancer.
放射性金间质近距离治疗前列腺癌——最初使用液态金，后来采用种子技术——已有四十多年的经验。活检结果阴性率接近80%，5年时，A期和B1期的癌症特异性生存率为100%，B2期为90%，C期为76%，这种治疗方式为局限性前列腺癌患者提供了一种有效且耐受性良好的替代治疗模式。
